Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial.

Saved in:
Bibliographic Details
Title: Evaluation of Neutrophil to Lymphocyte Ratio in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With a Combination of Cetuximab and Nivolumab in a Phase II Clinical Trial.
Authors: Park R; Department of Head and Neck-Endocrine Oncology., Rind F; Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Kristoff T; Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA., Li J; Biostatistics and Bioinformatics., Schell M; Biostatistics and Bioinformatics., Slebos RJC; Department of Head and Neck-Endocrine Oncology., Thatikonda S; Department of Head and Neck-Endocrine Oncology., Chaudhary R; Department of Head and Neck-Endocrine Oncology., Biernacki MI; Department of Head and Neck-Endocrine Oncology., Meshkovska Y; Department of Head and Neck-Endocrine Oncology., Kaldas D; Department of Head and Neck-Endocrine Oncology.; Department of Internal Medicine, University of South Florida, Tampa, FL., Kim HS; College of Osteopathic Medicine, Nova Southeastern University, Davie, FL., Farinhas J; Radiology., Hernandez-Prera J; Pathology., Kirtane K; Department of Head and Neck-Endocrine Oncology., Hall MS; Immunology., Amelio AL; Department of Head and Neck-Endocrine Oncology.; Tumor Microenvironment and Metastasis, Moffitt Cancer Center, Tampa, FL., Rocco JW; Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, James Cancer Hospital/Solove Research Institute, Columbus, OH., Bhateja P; Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Steuer C; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Bonomi M; Department of Internal Medicine and The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH., Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Chung CH; Department of Head and Neck-Endocrine Oncology.
Source: American journal of clinical oncology [Am J Clin Oncol] 2026 Apr 01; Vol. 49 (4), pp. 176-187. Date of Electronic Publication: 2025 Sep 04.
Publication Type: Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-453X
DOI:10.1097/COC.0000000000001255